Very relevant post greens. Positive phase 2's can be significant catalysts. Especially given lack of available similar treatments on market for our product/class, esp w unique indication they are seeking initial approval for, further differentiating the product from other companies. Things hopefully get interesting over next two weeks. Being close to a month out is quickly becoming crunch time
News 
Market Data 
Discover 
